English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regeneron Pharmaceuticals, Inc
Press release submission
| Jan 2, 2021
REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
Press release submission
| Jul 5, 2020
Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients
Carol Ostrow
| Sep 23, 2017
Study shows Dupixent reduces symptoms of atopic dermatitis
Ruth de Jauregui
| May 7, 2017
Survey finds majority of rheumatoid arthritis patients living in pain
Ruth de Jauregui
| Apr 2, 2017
FDA approves Dupixent for atopic dermatitis
Trending
Patient Daily
| Aug 1, 2025
Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily
| Aug 4, 2025
Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+
Pharmaceuticals
Patient Daily
| Aug 5, 2025
American Lung Association study urges schools to prioritize clean classroom air
Patient Daily
| Aug 7, 2025
Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews
